Get started
Author

René Swanink

The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder
2007 · Robert M. Berman, Ronald N. Marcus, et al. · The Journal of Clinical Psychiatry · 410
Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants
2009 · Robert M. Berman, Maurizio Fava, et al. · CNS Spectrums · 260
Effectiveness of aripiprazole v. Haloperidol in acute bipolar mania
2005 · Eduard Vieta, Michel Bourin, et al. · The British Journal of Psychiatry · 173
PDF
Aripiprazole for the Treatment of Psychoses in Institutionalized Patients With Alzheimer Dementia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Assessment of Three Fixed Doses
2007 · Jacobo E. Mintzer, Larry E. Tune, et al. · American Journal of Geriatric Psychiatry · 157
Aripiprazole for the Treatment of Psychosis in Patients With Alzheimer's Disease
2005 · Peter De Deyn, Dilip V. Jeste, et al. · Journal of Clinical Psychopharmacology · 150
A Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole for the Treatment of Psychosis in Nursing Home Patients with Alzheimer Disease
2008 · Joel E. Streim, Anton P. Porsteinsson, et al. · American Journal of Geriatric Psychiatry · 114
Dasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II Trial
2018 · Lia Gore, Pamela R. Kearns, et al. · Journal of Clinical Oncology · 103
PDF
A Double-Blind, Randomized Comparative Study of Aripiprazole and Olanzapine in Patients with Schizophrenia
2008 · W. Wolfgang Fleischhacker, Robert D. McQuade, et al. · Biological Psychiatry · 103
Efficacy, dose–response relationship and safety of once‐daily extended‐release metformin (Glucophage® XR) in type 2 diabetic patients with inadequate glycaemic control despite prior treatment with diet and exercise: results from two double‐blind, placebo‐controlled studies
2004 · K. Fujioka, R. L. Brazg, et al. · Diabetes Obesity and Metabolism · 73
Abatacept in subjects who switch from intravenous to subcutaneous therapy: results from the phase IIIb ATTUNE study
2012 · Edward Clark Keystone, Joel M Kremer, et al. · Annals of the Rheumatic Diseases · 53
Examining the Efficacy of Adjunctive Aripiprazole in Major Depressive Disorder
2008 · Michael E. Thase, Mudhukar H. Trivedi, et al. · The Primary Care Companion to The Journal of Clinical Psychiatry · 47
CA180-372: An International Collaborative Phase 2 Trial of Dasatinib and Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
2017 · Stephen P. Hunger, Vaskar Saha, et al. · Blood · 30
PDF
Nivolumab for Relapsed or Refractory (r/r) Classical Hodgkin Lymphoma (chl) After Autologous Transplantation: 5‐year Overall Survival From the Phase 2 Checkmate 205 Study
2021 · S. M. Ansell, P. J. Bröckelmann, et al. · Hematological Oncology · 19
PDF
HL-398: Five-Year Overall Survival from the CheckMate 205 Study of Nivolumab for Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL)
2021 · Stephen Ansell, Paul Bröckelmann, et al. · Clinical Lymphoma Myeloma & Leukemia · 16
The safety and efficacy of dasatinib plus nivolumab in patients with previously treated chronic myeloid leukemia: results from a phase 1b dose-escalation study
2021 · Joaquín Martínez-López, Satu Mustjoki, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 14
649 A Randomized Placebo-Controlled Trial of Abatacept for Moderately-to-Severely Active Crohn's Disease (CD)
2010 · Stephen B. Hanauer, William J. Sandborn, et al. · Gastroenterology · 11
P1-330 Flexible-dose aripiprazole in psychosis of Alzheimer's disease
2004 · Joel Streim, Christopher Breder, et al. · Neurobiology of Aging · 6
Final results of CA180-372/COG AALL1122 phase 2 trial of dasatinib and chemotherapy in pediatric patients with newly-diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (PH plus ALL)
2020 · Stephen P. Hunger, Vaskar Saha, et al. · 4
P1-326 Dose-ranging study of aripiprazole in patients with dementia of Alzheimer's disease
2004 · Christopher Breder, Rene Swanink, et al. · Neurobiology of Aging · 3
Phase II trial of dasatinib (DAS) in pediatric patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP).
2017 · Lia Gore, Pamela Kearns, et al. · Journal of Clinical Oncology · 2
P.2.064 A dose-ranging study of aripiprazole treatment in patients with psychosis associated with Alzheimer's dementia
2004 · D. Kostic, C. Breder, et al. · European Neuropsychopharmacology · 2
Impact of Comorbidities on Response Outcomes in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with First-Line Dasatinib Versus Imatinib: Exploratory Post Hoc Analysis of DASISION
2020 · Massimo Breccia, Michael J. Mauro, et al. · Blood · 1
CML-081: Effect of Comorbidities on Response Outcomes with First-Line Tyrosine Kinase Inhibitors (TKIs), Dasatinib Versus Imatinib, in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Exploratory Post Hoc Analysis of DASISION
2021 · Massimo Breccia, Michael Mauro, et al. · Clinical Lymphoma Myeloma & Leukemia
Poster: HL-398: Five-Year Overall Survival from the CheckMate 205 Study of Nivolumab for Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL)
2021 · Stephen Ansell, Paul Bröckelmann, et al. · Clinical Lymphoma Myeloma & Leukemia
Poster: CML-081: Effect of Comorbidities on Response Outcomes With First-Line Tyrosine Kinase Inhibitors (TKIs), Dasatinib Versus Imatinib, in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Exploratory Post Hoc Analysis of DASISION
2021 · Massimo Breccia, Michael Mauro, et al. · Clinical Lymphoma Myeloma & Leukemia
Works count: 27
Citation count: 1,751
H-index: 14
I10-index: 16
Year
Topic
Type